Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GEn1E-1124

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
In this early phase clinical research study, the investigational drug will be administered to 64 healthy volunteers in a double-blind, placebo-controlled manner, at a one research center. The objectives of the study are to assess what the body does to the investigational drug, what the investigational drug does to the body and also to observe the safety and tolerability of the investigational drug healthy volunteers.
Epistemonikos ID: 44f7189c5609e30422bb74b137059ab9144d3562
First added on: May 08, 2024